Cannabis Business Times' Best Cannabis Companies to Work For - 2027 Is Accepting Entries! Enter now.
Cannabis Business Times' Best Cannabis Companies to Work For - 2027 Is Accepting Entries! Enter now.
Ohio Medical Board Delays Vote on New Conditions for Medical Marijuana | Cannabis Business Times

Create a free Cannabis Business Times account to continue reading

Continue to Site »
Site will load in 15 seconds

Ohio Medical Board Delays Vote on New Conditions for Medical Marijuana

The board has postponed a vote on whether to add anxiety and autism spectrum disorder to the state's list of qualifying conditions for medical marijuana.

Ohio Capitol Building Adobe Stock Credit Katherine Resized
Top photo: © Katherine | Adobe Stock
Fox 8 (Cleveland)
June 13, 2019

COLUMBUS, Ohio — The State Medical Board of Ohio has postponed a vote on adding anxiety and autism spectrum disorder to the state's list of qualifying conditions for purchasing medical marijuana.

Board President Dr. Michael Schottenstein said Wednesday the vote would be delayed to give two new board members time to consider expert reports.

Read more

Recommended
8th Annual ‘Best Cannabis Companies to Work For’ Now Open for Entries
Sponsored
8th Annual ‘Best Cannabis Companies to Work For’ Now Open for Entries
Kema Ogden Opinion
The Hemp Loophole Is Closing, But We Still Need to Fix What It Broke (Opinion)
Handcuffs 585853083
Louisiana Bid for Adult-Use Cannabis Pilot Program Dies; Governor Signs Recriminalization Bill Instead
Cannabis Lawsuit 1661643602
5 ‘Aggrieved Persons’ Sue Trump, DOJ Over Cannabis Rescheduling Order
Related Stories
Signing Petition Adobe Stock Credit Nonwarit Resized
Mississippi Medical Marijuana Initiative Closes In on Enough Signatures for 2020 Ballot
Oregon Capitol Adobe Stock Credit Jpldesigns Resized
Legislature Passes Bill Preparing Oregon for Possible Interstate Cannabis Sales
Hemp Oil Seeds Adobe Stock Credit Kostrez Resized
International Hemp Industry Hopes to Change U.S.’s 0.3-Percent THC Limit
Maine Statehouse
Maine’s Biggest Marijuana Company Threatens to Sue State If It’s Shut Out of Recreational Market
More in Legislation and Regulation
Anti-Rescheduling Parties Ask Court to Stay Schedule III Cannabis Order
A national drug screening association and a private pharmaceutical cannabinoid development company argue they’ll suffer irreparable harm.
Mj Gavel 200627444
The Hemp Loophole Is Closing, But We Still Need to Fix What It Broke (Opinion)
Congress is finally moving to regulate hemp-derived THC. Licensed cannabis operators have been waiting years for this moment. Now we need to make sure it actually sticks.
Kema Ogden Opinion
Louisiana Bid for Adult-Use Cannabis Pilot Program Dies; Governor Signs Recriminalization Bill Instead
The state took a turn in 2026 to tighten its cannabis laws rather than loosen them, despite a Schedule III federal posture from the Trump administration.
Handcuffs 585853083
5 ‘Aggrieved Persons’ Sue Trump, DOJ Over Cannabis Rescheduling Order
A substance abuse recovery clinic, two doctors, a victims’ advocacy organization and a pharmaceutical company claim the order was unlawful.
Cannabis Lawsuit 1661643602
7 House Democrats Demand IRS, Treasury Provide 280E Cannabis Guidance
The U.S. representatives sent a letter urging ‘clear, timely guidance’ for state-licensed medical businesses following the DOJ’s rescheduling order.
280 E Irs 384033554
3 US House Republicans Attempt to Thwart Intoxicating Hemp Product Ban
The GOP lawmakers filed three proposed amendments to a federal appropriations bill to modify, delay or stop the ban’s forthcoming implementation.
U.S. House Reps. Andy Barr, R-Ky., (from left), Russell Fry, R-S.C., and James Comer, R-Ky.
3 States Challenge Trump DOJ’s Schedule III Cannabis Rule
Nebraska, Indiana and Louisiana filed a petition for review in federal court, arguing that immediately rescheduling medical cannabis violates administrative procedures.
Cannabis Gavel 310460178
White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May
The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.
Top10 May 2026
SAFE Banking Act Nowhere to Be Found in Wake of Schedule III Cannabis Order
The new federal posture toward loosening restrictions on cannabis does not appear to have increased congressional appetite for industry banking reform.
U.S. Sens. Tim Scott, R-S.C., (left) and Jeff Merkley, D-Ore.
Cannabis Business Leans on Schedule III Listing, Asks US Tax Court to Recognize 280E Refunds for Prior Years
The IRS can’t dispute that medical cannabis falls outside the meaning of Schedule I or II ‘without contradicting the president, the acting attorney general and HHS,’ the company says.
Tax Money 347197133
Virginia Governor Blocks Adult-Use Dispensary Sales Bill
Gov. Abigail Spanberger vetoed legislation that would have legalized a licensed marketplace with a January 2027 dispensary sales launch.
Virginia Gov. Abigail Spanberger vetoed an adult-use cannabis sales bill on May 19.
Former Federal Prosecutor, Former IRS Lawyer Warn Cannabis Industry About Jumping on DEA Registration Bandwagon
The takeaway? Consult with experienced lawyers and tax professionals and consider the risks, as the landscape continues to shift.
Dea Jws 682322766 Editorial Use Only
Page 1 of 507
Next Page